---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-124165"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2025-12-22T23:59:59+00:00"
generated_at: "2026-05-16T12:24:32.288599+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NeuroOne appoints Jason Mills, Penumbra EVP of Strategy, to Board of Directors

## Summary
- Board size increased to five; Mills appointed as Class I director effective Dec 18, 2025.
- Mills will serve on Compensation and Nominating & Corporate Governance Committees.
- Mills is EVP of Strategy at Penumbra (PEN), a leading thrombectomy company.
- Previously Managing Director and head of med-tech research at Canaccord Genuity for 13+ years.

## SEC filing metadata
- accession: 0001213900-25-124165
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2025-12-22T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390025124165/0001213900-25-124165-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390025124165/ea0270439-8k_neuroone.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-124165
- JSON: https://secwatch.observer/filing/0001213900-25-124165.json
- Plain text: https://secwatch.observer/filing/0001213900-25-124165.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.